לפונקס 25 מ"ג טבליות

Country: Իսրայել

language: եբրայերեն

source: Ministry of Health

active_ingredient:

CLOZAPINE 25 MG

MAH:

NOVARTIS PHARMA SERVICES AG

ATC_code:

N05AH02

pharmaceutical_form:

TABLETS

administration_route:

PER OS

manufactured_by:

NOVARTIS PHARMACEUTICALS LTD, UK

therapeutic_group:

CLOZAPINE

therapeutic_indication:

Treatment of resistant schizophrenic patients who are non-responsive to, or intolerant of classic neuroleptics. Reducing the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder who are judged to be at chronic risk for re-experiencing suicidal behavior, based on history and recent clinical state. Suicidal behavior refers to actions by a patient that put him/herself at risk for death.

authorization_date:

2012-10-01